| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.27 | 2e-08 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.2 | 0.0006 |